Full-Stack Python Engineer, Aqemia
3+ days a week in office
AI and quantum physics driven drug discovery
Open for applications
AI and quantum physics driven drug discovery
21-100 employees
Open for applications
3+ days a week in office
21-100 employees
Company mission
To design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology.
Role
Who you are
- 5+ years of experience as a software engineer in an engineering organisation of 20+ engineers
- Strong full-stack development experience with expertise in Python, FastAPI (or similar backend frameworks), SQL, Vue.js/React (or similar frontend framework)
- Proficiency in cloud infrastructure (AWS preferred, but other cloud experience is welcome)
- Knowledge of Kubernetes and DevOps principles (CI/CD, infrastructure as code) is a plus
- Proven ability to lead and deliver technical projects from start to finish
- Experience in designing and architecting complex software systems
- Ability to balance quality and fast iterations in a fast-paced environment
- Strong collaboration skills; ability to interact effectively with technical stakeholders
Desirable
- You are eager to play an active role in contributing to Aqemia’s strategy to develop drugs for patients
- You will bring strong knowledge and skills to inspire and coach brilliant people from diverse backgrounds
- You are keen to solve tough problems on issues that truly matter, with a proactive and a can-do attitude
- You thrive on working collaboratively in a fast-paced, interdisciplinary environment that keeps everyone on track
What the job involves
- As a Senior Full-Stack Engineer, you will play a pivotal role in building and improving the platform that powers Aqemia’s drug discovery efforts
- This is the first role of its kind at Aqemia, meaning you will have significant influence over engineering culture, best practices, and technical decisions
- You will be responsible for aligning engineering efforts across the company and ensuring our platform is robust, scalable, and efficient
- Design, build, and evolve reliable and scalable services running biochemical algorithms
- Lead full-stack development, improving both backend (FastAPI, Python, SQL) and frontend components
- Shape the engineering culture, defining best practices and ensuring high-quality code
- Act as a technical leader within the engineering team, making key architectural and stack decisions
- Work across the stack, from cloud infrastructure (AWS) to application development, ensuring seamless integration and performance
- Support and guide other engineers, fostering collaboration and technical excellence
- Operate in an Agile environment, participating in daily sprints and iterative development cycles
Application process
- 1 - Hiring Manager’s interview: you’ll meet directly with your future manager Aloÿs (1h, visio call)
- 2 - Technical assessment of your skills: live coding exercise in Python (45min, visio call)
- 3 - Technical assessment of your skills: system design collaborative exercise, plus a tour of our offices (1h, in office)
- 4 - Cultural fit interview with our co-founder and COO Emmanuelle (45min)
- 5 - Final interview with our co-founder and CEO Maximilien (45min)
Our take
The billion dollar drug discovery industry is set to see notable growth by 2032 with huge R&D investments being made. It’s generally accepted that this is one of the most important financed sectors in the world. AQEMIA joined the discovery train in 2019 with its deep physics and AI enabled drug revelation pipeline.
The company boasts its intricate level of accuracy within its physics algorithms that are fed into AI discovery, leading to a level of speed and in turn scaling drug discovery at an impressive rate. Creating a name for itself AQEMIA moves away from using experimental data and bases the AI powered outcomes on years of data and studies of its now impressive team of 50.
Aqemia’s discoveries have already made an impact in oncology and immuno-oncology trials. The company sets goals to be part of more life changing clinical trials with wholly or partly owned drug candidates and with significant funding continues to scale its platform to continue wins in its research. It will be exciting to see how more research and collaborations like that with Servier (international pharmaceutical company) will continue to grow its success.
Steph
Company Specialist at Welcome to the Jungle
Company
Funding (last 2 of 6 rounds)
Apr 2025
$7.4m
GRANT
Dec 2024
$41.3m
EARLY VC
Total funding: $129.7m
Company HQ
Necker, Paris, France
Leadership
Maximilien Levesque
(Co-Founder & CEO)Currently a Board Member of France Biotech. Founded Personal HPC and worked through several roles at École normale supérieure most recently as a Research Group Leader.
Emmanuelle Martiano Rolland
(Co-Founder & COO)Previous Principal at Boston Consulting Group after completing a Master of Science Imperial College of London.
Share this job
View 1 more job at Aqemia